Tapewire

Nasdaq · USD

ORMP

ORAMED PHARMACEUTICALS INC.

Export transactions ↓
Tapewire entity
6311
SEC CIK
0001176309
Parsed reports
201

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202602
Aug 202600
Sep 202600
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 31, 2025 Filed Jan 5, 2026 22:21 UTC GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-001282 · ownership.xml · nonDerivative · entry 1

Reznick Yehuda · CIK 0002015556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,930

F1 · shares: Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

F1 · price: Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:21 UTC
KIDRON NADAVDirector · President and CEO
GrantPerformance Stock Units · Derivative 109,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-001280 · ownership.xml · derivative · entry 4

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,000

Underlying: Common Stock · 109,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

F3 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

F3 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:21 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 327,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-001280 · ownership.xml · nonDerivative · entry 2

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,246,238

F2 · shares: Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

F2 · price: Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:21 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 232,640 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-001280 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,919,238

F1 · shares: Represents Restricted Stock Units ("RSUs") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

F1 · price: Represents Restricted Stock Units ("RSUs") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:21 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantPerformance Stock Units · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-001279 · ownership.xml · derivative · entry 3

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

F3 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

F3 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:21 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 115,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-001279 · ownership.xml · nonDerivative · entry 2

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,429,664

F2 · shares: Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

F2 · price: Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:21 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 121,331 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-001279 · ownership.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,314,664

F1 · shares: Represents Restricted Stock Units ("RSUs") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

F1 · price: Represents Restricted Stock Units ("RSUs") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:20 UTC
Hexter JoshuaCOO & CBO
GrantPerformance Stock Units · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-001278 · ownership.xml · derivative · entry 3

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

F3 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

F3 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:20 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 115,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-001278 · ownership.xml · nonDerivative · entry 2

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,045,495

F2 · shares: Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

F2 · price: Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:20 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 97,328 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-001278 · ownership.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 930,495

F1 · shares: Represents Restricted Stock Units ("RSUs") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

F1 · price: Represents Restricted Stock Units ("RSUs") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:20 UTC GrantCommon Stock 3,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-001277 · ownership.xml · nonDerivative · entry 2

Shapiro Benjamin · CIK 0001974846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,220

F2 · shares: Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

F2 · price: Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:20 UTC GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-001277 · ownership.xml · nonDerivative · entry 1

Shapiro Benjamin · CIK 0001974846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,720

F1 · shares: Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

F1 · price: Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:20 UTC
Mayer ArieDirector
GrantCommon Stock 4,900 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-001275 · ownership.xml · nonDerivative · entry 2

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,009

F2 · shares: Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

F2 · price: Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 22:20 UTC
Mayer ArieDirector
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-001275 · ownership.xml · nonDerivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,109

F1 · shares: Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

F1 · price: Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:08 UTC
Mayer ArieDirector
GrantCommon Stock 6,975 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052624 · ownership.xml · nonDerivative · entry 2

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,109

F2 · price: Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:08 UTC
Mayer ArieDirector
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052624 · ownership.xml · nonDerivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,134

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:08 UTC GrantCommon Stock 8,371 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052623 · ownership.xml · nonDerivative · entry 2

Aghion Daniel · CIK 0002004805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,191

F2 · price: Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:08 UTC GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052623 · ownership.xml · nonDerivative · entry 1

Aghion Daniel · CIK 0002004805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,820

F1 · price: . Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:08 UTC GrantCommon Stock 8,370 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052622 · ownership.xml · nonDerivative · entry 2

Reznick Yehuda · CIK 0002015556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,930

F2 · price: Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:08 UTC GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052622 · ownership.xml · nonDerivative · entry 1

Reznick Yehuda · CIK 0002015556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,560

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:07 UTC
Sank LeonardDirector
GrantCommon Stock 6,510 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052620 · ownership.xml · nonDerivative · entry 2

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,531

F2 · price: Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:07 UTC
Sank LeonardDirector
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052620 · ownership.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,021

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:07 UTC GrantCommon Stock 4,650 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052618 · ownership.xml · nonDerivative · entry 2

Shapiro Benjamin · CIK 0001974846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,720

F2 · price: Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:07 UTC GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-052618 · ownership.xml · nonDerivative · entry 1

Shapiro Benjamin · CIK 0001974846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,070

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:31 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 66,667 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012241 · ownership.xml · nonDerivative · entry 3

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,193,333

F3 · shares: Represents shares issued on settlement of PSUs previously granted on February 3, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:31 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 52,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012241 · ownership.xml · nonDerivative · entry 2

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,126,666

F2 · shares: Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:31 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 74,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012241 · ownership.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,074,666

F1 · shares: Represents shares issued on settlement of performance stock units ("PSUs") previously granted on January 4, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:31 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 33,334 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012240 · ownership.xml · nonDerivative · entry 3

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 833,167

F3 · shares: Represents shares issued on settlement of PSUs previously granted on February 3, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:31 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 48,500 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012240 · ownership.xml · nonDerivative · entry 2

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 799,833

F2 · shares: Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:31 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 45,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012240 · ownership.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 751,333

F1 · shares: Represents shares issued on settlement of performance stock units ("PSUs") previously granted on January 4, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:31 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012239 · ownership.xml · nonDerivative · entry 3

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,686,598

F3 · shares: Represents shares issued on settlement of PSUs previously granted on February 3, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:31 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 186,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012239 · ownership.xml · nonDerivative · entry 2

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,586,598

F2 · shares: Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:31 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 141,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012239 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,400,598

F1 · shares: Represents shares issued on settlement of performance stock units ("PSUs") previously granted on January 4, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:30 UTC
Gabay AvrahamChief Financial Officer
GrantCommon Stock 42,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012238 · ownership.xml · nonDerivative · entry 2

Gabay Avraham · CIK 0001777328 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 434,040

F2 · shares: Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
February 11, 2025 Filed Feb 11, 2025 21:30 UTC
Gabay AvrahamChief Financial Officer
GrantCommon Stock 34,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-012238 · ownership.xml · nonDerivative · entry 1

Gabay Avraham · CIK 0001777328 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,040

F1 · shares: Represents shares issued on settlement of performance stock units ("PSUs") previously granted on June 20, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:10 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 433,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-001168 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,259,598

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 36,125 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:10 UTC
Gabay AvrahamChief Financial Officer
GrantCommon Stock 188,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-001166 · ownership.xml · nonDerivative · entry 1

Gabay Avraham · CIK 0001777328 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 358,040

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 15,666 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:10 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 207,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-001169 · ownership.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,666

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 17,250 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:10 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 194,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-001165 · ownership.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 706,333

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 16,208 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 21:30 UTC
Gabay AvrahamChief Financial Officer
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-095932 · ownership.xml · nonDerivative · entry 1

Gabay Avraham · CIK 0001777328 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,040

F1 · price: Represents a grant of 30,000 Restricted Stock Units ("RSUs") that will vest on November 7, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 21:30 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 45,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-095931 · ownership.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,826,098

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest on November 7, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 21:30 UTC
Kidron MiriamChief Scientific Officer
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-095930 · ownership.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 793,666

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest on November 7, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 21:30 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-095929 · ownership.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 511,833

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest on November 7, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 21, 2024 Filed Jun 21, 2024 20:15 UTC
Gabay AvrahamChief Financial Officer
GrantCommon Stock 140,040 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-054781 · ownership.xml · nonDerivative · entry 1

Gabay Avraham · CIK 0001777328 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: Represents a grant of 140,040 Restricted Stock Units ("RSUs"), of which 93,360 will vest on June 18, 2026 and the remaining 46,680 will vest in four equal quarterly installments of 11,670 starting September 18, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 21:15 UTC GrantCommon Stock 760 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-051336 · ownership.xml · nonDerivative · entry 1

Reznick Yehuda · CIK 0002015556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,560

F1 · price: Represents a grant of 760 Restricted Stock Units ("RSUs") that will vest in two equal installments on October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 17, 2024 Filed Apr 19, 2024 00:07 UTC GrantCommon Stock 29,800 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-034222 · ownership.xml · nonDerivative · entry 1

Reznick Yehuda · CIK 0002015556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,800

F1 · price: Represents (i) a grant of 22,500 Restricted Stock Units ("RSUs") that will vest in equal installments on January 1, 2025, January 1, 2026 and January 1, 2027 and (ii) grants of 5,070 and 2,230 RSUs that will each vest in nearly equal installments on July 1, 2024, October 1, 2024 and January 1, 2025. In each case, the RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 30, 2024 Filed Jan 30, 2024 22:30 UTC GrantCommon Stock 3,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002429 · doc4.xml · nonDerivative · entry 1

Aghion Daniel · CIK 0002004805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,820

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 937 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:43 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 295,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001154 · doc4.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 763,666

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 24,625 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:41 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 329,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001151 · doc4.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,781,098

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 27,417 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:40 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 180,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001148 · doc4.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 481,833

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 15,042 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.